Evgen Pharma Share Discussion Threads

[moneymunch] 22/1/2021 14:36

Anyways, if the share price was 50p I wouldn't be selling any of mine, and am not concerned about where we are at, only where we're going...positive validation data permitting. Gl :-)

[moneymunch] 22/1/2021 14:33

Lol Sherlock..when did that last happen then???

Ps you'll probably find those that use Spreadex and the rest who bang on about a placing every 5 minutes are responsible for dragging the share price down.

[dutch123] 22/1/2021 14:26

All we need is positive news..ffs

[on target] 22/1/2021 14:23

I'm not Nobby's lackey no, but have had some suspicions of a link between you and whoever is dragging this down. It does seem to tend to rise when you're not around.

[moneymunch] 22/1/2021 14:19

Lol On target, are you Nobby's lackey, I've added loads over my time invested here, and never once through Spreadex...hit a button and the trade you've boasted about buying becomes a short...Gl :-)

[on target] 22/1/2021 14:14

Well you never ever see MM talk about buying or topping up, which is a bit suspicious.

[nobbygnome] 22/1/2021 13:55

Absolutely shocking price action! Is MM baling out? We need to be told....

[on target] 22/1/2021 12:36

No wonder we can't hold a rise when people give up after 3 hours ffs

22-Jan-21 08:17:39 12.50 114,292 Buy* 11.75 12.25 14.29k O
22-Jan-21 11:33:02 11.30 114,292 Sell* 11.25 11.50 12.91k O

[moneymunch] 22/1/2021 12:21

Roll on next week...Perfectly poised and primed for market appreciation imho...Gla :-)

[peanut100] 22/1/2021 12:00

So deserves to be down on the day, terrible news this week. Obviously using the news to raise cash it feels. Unreal response to 3 bits of great news.

[bumpa33] 22/1/2021 09:46

I’d agree with Stig on that - a raise to more aggressively pursue opportunities would be seen as a plus by the mkt. Not saying they will, but i would view it as a clear positive.

[rickus] 22/1/2021 09:41

Would someone be kind enough please to give me a better understanding of pre-clinical data.

I assume that the trials can vary quite considerably - even the spelling of pre-clinical varied in the two recent announcements!

Are there any specific criteria that have to be applied to the trials other than that they do not involve testing on humans?

Will the company have specified trial protocols and end points? e.g.
Do we have more information on the nature of these trials?
Would the data to underpin the last two releases have been specifically targeted or is it more likely that they released the information as soon as they uncovered some meaningful evidence?

What is the context of these two trials - i.e. what is it reasonable to assume would follow on?

Do these two trials in any way compliment each other or any of the other work being undertaken by the company?

[the stigologist] 22/1/2021 09:30

Maybe EVG and their shareholders need to stop being so smalltime

Dilution isn't bad

REDX and MPH did big DILUTIVE fundings and stocks rocketed

"The business model is to seek non-dilutive funding to advance the pipeline towards commercial JV partnerships"

[markth126] 22/1/2021 09:18

added 2 x 50k chunks today, surprised one of them below 12p still but very happy to lock them away. Great news today imo

[moneymunch] 22/1/2021 08:54

The profit takers will be mopped up soon enough i reckon, and then more upside momentum thereafter, with any luck. Gla ;-)

[nobbygnome] 22/1/2021 08:52

The sellers are out as usual! Someone doesn't see the undervaluation here....

[moneymunch] 22/1/2021 08:33

The business model is to seek non-dilutive funding to advance the pipeline towards commercial JV partnerships....and Evgen have more opportunities for a lucrative JV or two than most. Gla ;-)

[moneymunch] 22/1/2021 08:31

They don't need to raise cash...Huw stated last month they have enough to the end of this year....and so he wouldn't likely highlight the favourable cash position if he was planning a fund raise anytime soon....and a lucrative commercial JV partner or two cold be waiting in the wings imho.....Gl ;-)

[montyhedge] 22/1/2021 08:23

All encouraging news, have they the cash to pursue or will there be a fund raising.

[tomboyb] 22/1/2021 08:21

Unbelievable -

[someuwin] 22/1/2021 08:17

finnCap...

"Evgen Pharma (EVG): Corp

SHP2 – a new oncology target for SFX-01

Further to the announcement of pre-clinical activity of SFX-01 in brain cancer (glioma), Evgen announced pre-clinical data demonstrating that SFX-01 is an inhibitor of SHP2, a molecule associated with a range of cancers and recognised as a biologically validated target as evidenced by early Phase I trials for this drug class (eg. Novartis Phase I study with TNO155). Given the well documented safety profile of SFX-01, we would envisage interest from pharma companies. Our current target price is underpinned by the use of SFX-01 in metastatic breast cancer (Phase IIb-ready), but with SFX-01 in STAR trial (ARDS +/- COVID-19) and the positive pre-clinical data in glioma models, it is increasingly clear that Evgen as multiple shots on goal and that there is potential for significant value accretion from the 25p target. Clinical successes and/or licensing deals could generate multiple returns from the current price level."

[peanut100] 22/1/2021 08:14

I'm thinking they'll be doing a proper update and note on all the recent news so revisit their PT - perhaps when the breast cancer news comes out.....next week?

[tomboyb] 22/1/2021 08:09

15p+ today -

lets see -

[moneymunch] 22/1/2021 08:03

Evgen look all set for a one way trajectory from small cap to mid cap Bio imho, and validation of SFX-01 and a commercial JV or two , and wouldn't be surprised to see Evgen move to a Nasdaq listing in the not too distant future, where real value and appreciation will be realised to the full. Gla holders...i can't think of many other Bio's at this current bargain low that offers so much UPside as Evgen's prospects and potential...Exciting times!!! ;-)